Ibezapolstat
N/A
Report date: 2026/04/08 20:02:35
NMEQIDP
Base Information
Drug NameIbezapolstat
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlsynthesis Inc
China Registration ClassN/A
Develop Information
Active CompaniesAcurx Pharmaceuticals Llc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A